Equillium
Jeanette Ampudia is currently the Director of Immunology and Research Operations at Equillium, Inc., overseeing assay development for pipeline assets. Previously, Jeanette held roles at aTyr Pharma and Takeda California, focusing on in vitro cell biology assay development and translational studies. Jeanette also has experience at BioLegend and TSRI, with a background in managing labs and conducting independent research projects. With a Bachelor of Science in Marine Science/Biology pathway from the University of San Diego, Jeanette has a strong foundation in scientific research and operations.
Equillium
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer new products with a mission to dramatically improve the lives of patients with severe autoimmune and inflammatory diseases who continue to suffer with high unmet medical needs.